Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulte…
Continue reading at thesicktimes.org.
No webmentions yet
Replies, likes, reposts, and mentions will show up here when they arrive.